| The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | BMJ, The | 2021 | 4.5K |
| PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews | BMJ, The | 2021 | 666 |
| The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | Systematic Reviews | 2021 | 513 |
| The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | International Journal of Surgery | 2021 | 461 |
| The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | PLoS Medicine | 2021 | 286 |
| Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement | Journal of Clinical Epidemiology | 2021 | 279 |
| Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 | New England Journal of Medicine | 2021 | 203 |
| The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | Journal of Clinical Epidemiology | 2021 | 201 |
| American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 | Blood Advances | 2021 | 161 |
| Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews | Journal of Clinical Epidemiology | 2021 | 109 |
| American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer | Blood Advances | 2021 | 96 |
| Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial | BMJ, The | 2021 | 54 |
| Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease | Kidney International | 2021 | 51 |
| Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report | Chest | 2021 | 48 |
| The effect of COVID-19 pandemic on the mental health of Canadian critical care nurses providing patient care during the early phase pandemic: A mixed method study | Intensive and Critical Care Nursing | 2021 | 46 |
| Venous thromboembolism | Lancet, The | 2021 | 40 |
| Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles | Journal of Extracellular Vesicles | 2021 | 38 |
| Defining Rapid Reviews: a systematic scoping review and thematic analysis of definitions and defining characteristics of rapid reviews | Journal of Clinical Epidemiology | 2021 | 37 |
| Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report | Chest | 2021 | 35 |
| Endothelial cells in the pathogenesis of pulmonary arterial hypertension | European Respiratory Journal | 2021 | 30 |
| Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial | Lancet Neurology, The | 2021 | 27 |
| The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | Revista Espanola De Cardiologia (English Ed ) | 2021 | 23 |
| Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells | Autophagy | 2021 | 22 |
| A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer | European Journal of Cancer | 2021 | 20 |
| LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy | EBioMedicine | 2021 | 15 |
